Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · IEX Real-Time Price · USD
5.90
-0.14 (-2.32%)
Jul 19, 2024, 4:30 PM EDT - Market closed
Foghorn Therapeutics Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for FHTX stock have an average target of 13, with a low estimate of 6.00 and a high estimate of 20. The average target predicts an increase of 120.34% from the current stock price of 5.90.
Analyst Consensus: Buy
* Price targets were last updated on May 7, 2024.
Analyst Ratings
The average analyst rating for FHTX stock from 3 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 2 | 2 | 2 | 1 |
| Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 5 | 4 | 4 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +238.98% | May 7, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +238.98% | May 1, 2024 |
| Wedbush | Wedbush | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Apr 10, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $20 | Strong Buy | Reiterates | $20 | +238.98% | Apr 10, 2024 |
| Wedbush | Wedbush | Buy Reiterates $13 | Buy | Reiterates | $13 | +120.34% | Mar 8, 2024 |
Financial Forecast
Revenue This Year
28.96M
from 34.16M
Decreased by -15.21%
Revenue Next Year
31.46M
from 28.96M
Increased by 8.63%
EPS This Year
-2.21
from -2.34
EPS Next Year
-1.72
from -2.21
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 36.9M | 56.7M | 67.2M | 102.7M | 342.7M |
| Avg | 29.0M | 31.5M | 38.6M | 91.2M | 224.7M |
| Low | 21.3M | n/a | n/a | 76.3M | 160.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 7.9% | 95.8% | 113.6% | 166.0% | 275.8% |
| Avg | -15.2% | 8.6% | 22.8% | 136.2% | 146.4% |
| Low | -37.5% | - | - | 97.7% | 75.5% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -2.07 | -1.14 | -0.95 | -1.44 | -0.36 |
| Avg | -2.21 | -1.72 | -1.73 | -1.40 | -0.35 |
| Low | -2.51 | -2.31 | -2.23 | -1.34 | -0.33 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | - |
| Avg | - | - | - | - | - |
| Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.